Tranexamic acid for childbirth: why, when, and for whom
Loı̈c Sentilhes(Université de Bordeaux), Catherine Deneux‐Tharaux(Inserm), Hugo Madar(Hôpital Cochin), Benjamin Merlot(Unknown), Alizée Froeliger(Université de Bordeaux), Aurélien Mattuizzi(Hôpital Pellegrin), B. Elleboode(Université de Bordeaux)
Cited by 18
Related Papers
Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection
|JAMA Pediatrics|2021|1.4k
Preeclampsia and COVID-19: results from the INTERCOVID prospective longitudinal study
|American Journal of Obstetrics and Gynecology|2021|310
Tranexamic Acid for the Prevention of Blood Loss after Cesarean Delivery
|New England Journal of Medicine|2021|272
Coronavirus disease 2019 in pregnancy was associated with maternal morbidity and preterm birth
|American Journal of Obstetrics and Gynecology|2020|197
Underreporting of Pregnancy-Related Mortality in the United States and Europe
|Obstetrics and Gynecology|2005|188